O fator neurotrófico derivado do cérebro (BDNF) tem sido associado com a angiogênese por meio do seu receptor específico tropomiosina quinase B (TrkB). Uma vez que ambos são expressos em células endoteliais vasculares e o treinamento físico aeróbio (TF) pode aumentar os níveis séricos de BDNF, este estudo teve como objetivo testar as hipóteses de que: 1) Os níveis séricos de BDNF modulam o fluxo de sangue periférico; e 2) A presença do alelo Met no polimorfismo BDNF Val66Met prejudica o ganho de vasodilatação por TF. Foram genotipados para o polimorfismo do gene BDNF 304 voluntários saudáveis do sexo masculino (Val66Val, n = 221; Val66Met, n = 83) que foram submetidos a intenso TF em uma pista de corrida 3 vezes/semana durante 4 meses. Foram avaliados pré e pós-TF as concentrações circulantes de BDNF e pró-BDNF (ELISA), frequência cardíaca (FC), pressão arterial média (PAM), o fluxo de sangue do antebraço (FSA) e resistência vascular periférica (RVP). No período pré-TF, BDNF, pró-BDNF, a razão BDNF/pró-BDNF, FSA e RVP foram semelhantes entre todos os genótipos. Depois do TF, a capacidade funcional (VO2pico) aumentou e houve a diminuição da FC de repouso de forma semelhante em ambos os grupos. O grupo Val66Val, mas não o Val66Met, aumentou os níveis de BDNF (interação, p=0,04) e aumentou a razão BDNF/pró-BDNF (interação, p < 0,001). Curiosamente, as respostas do FSA (Interação, p=0,04) e da RVP (Interação, p=0,01), durante o exercício handgrip, do grupo Val66Val, apresentou melhoras quando comparado com o grupo Val66Met, mesmo com respostas similares de FC e PAM. Outras análises mostraram associação entre a razão BDNF/pró-BDNF e FSA (R=0,64; p < 0,001) e RVP (R=-0,58; p < 0,001). Estes resultados mostram que, em resposta ao TF, tanto a reatividade vascular periférica quanto o BDNF circulante são prejudicados pela presença do polimorfismo Val66Met do gene BDNF e esta responsividade está associada às concentrações de BDNF sérico em indivíduos saudáveis / The neurotrophin Brain-derived neurotrophic factor (BDNF) has been associated with angiogenesis through its specific receptor tropomyosin-related kinase B (TrkB). Since both are expressed in vascular endothelial cells and aerobic training (ET) can increase serum BDNF levels, this study aimed to test the hypotheses that: 1) Serum BDNF levels modulate peripheral blood flow; and 2) The presence of the allele Met in the BDNF Val66Met polymorphism impairs vasodilation gain by ET. We genotyped for BDNF polymorphism 304 healthy male volunteers (Val66Val, n= 221; Val66Met, n=83) which underwent to intense aerobic ET on a running track 3 times/week for 4 months. We evaluated pre and post ET serum BDNF and proBDNF concentration (ELISA), heart rate (HR), mean blood pressure (MBP), forearm blood flow (FBF) and forearm vascular resistance (FVR). In the pre ET, BDNF, proBDNF, BDNF/proBDNF ratio, FBF and FVR were similar between all genotypes. After ET, functional capacity (VO2peak) increased and HR decreased similarly in both groups. Val66Val, but not Val66Met, increased BDNF (Interaction, p= 0.04) and BDNF/proBDNF ratio (Interaction, p < 0.001). Interestingly, FBF (Interaction, p=0.04) and the FVR (Interaction, p=0.01) responses during handgrip exercise improved in Val66Val compared with Val66Met, even with similar responses of HR and MBP. Further analyses showed association between BDNF/proBDNF ratio and FBF (R=0.64, p < 0.001) and FVR (R=-0.56, p < 0001). These results show that peripheral vascular reactivity and serum BDNF responses to ET are impaired by the BDNF Val66Met polymorphism and such responsiveness is associated to the serum BDNF concentrations in healthy subjects

O fator neurotrófico derivado do cérebro (BDNF) tem sido associado com a angiogênese por meio do seu receptor específico tropomiosina quinase B (TrkB). Uma vez que ambos são expressos em células endoteliais vasculares e o treinamento físico aeróbio (TF) pode aumentar os níveis séricos de BDNF, este estudo teve como objetivo testar as hipóteses de que: 1) Os níveis séricos de BDNF modulam o fluxo de sangue periférico; e 2) A presença do alelo Met no polimorfismo BDNF Val66Met prejudica o ganho de vasodilatação por TF. Foram genotipados para o polimorfismo do gene BDNF 304 voluntários saudáveis do sexo masculino (Val66Val, n = 221; Val66Met, n = 83) que foram submetidos a intenso TF em uma pista de corrida 3 vezes/semana durante 4 meses. Foram avaliados pré e pós-TF as concentrações circulantes de BDNF e pró-BDNF (ELISA), frequência cardíaca (FC), pressão arterial média (PAM), o fluxo de sangue do antebraço (FSA) e resistência vascular periférica (RVP). No período pré-TF, BDNF, pró-BDNF, a razão BDNF/pró-BDNF, FSA e RVP foram semelhantes entre todos os genótipos. Depois do TF, a capacidade funcional (VO2pico) aumentou e houve a diminuição da FC de repouso de forma semelhante em ambos os grupos. O grupo Val66Val, mas não o Val66Met, aumentou os níveis de BDNF (interação, p=0,04) e aumentou a razão BDNF/pró-BDNF (interação, p < 0,001). Curiosamente, as respostas do FSA (Interação, p=0,04) e da RVP (Interação, p=0,01), durante o exercício handgrip, do grupo Val66Val, apresentou melhoras quando comparado com o grupo Val66Met, mesmo com respostas similares de FC e PAM. Outras análises mostraram associação entre a razão BDNF/pró-BDNF e FSA (R=0,64; p < 0,001) e RVP (R=-0,58; p < 0,001). Estes resultados mostram que, em resposta ao TF, tanto a reatividade vascular periférica quanto o BDNF circulante são prejudicados pela presença do polimorfismo Val66Met do gene BDNF e esta responsividade está associada às concentrações de BDNF sérico em indivíduos saudáveis / The neurotrophin Brain-derived neurotrophic factor (BDNF) has been associated with angiogenesis through its specific receptor tropomyosin-related kinase B (TrkB). Since both are expressed in vascular endothelial cells and aerobic training (ET) can increase serum BDNF levels, this study aimed to test the hypotheses that: 1) Serum BDNF levels modulate peripheral blood flow; and 2) The presence of the allele Met in the BDNF Val66Met polymorphism impairs vasodilation gain by ET. We genotyped for BDNF polymorphism 304 healthy male volunteers (Val66Val, n= 221; Val66Met, n=83) which underwent to intense aerobic ET on a running track 3 times/week for 4 months. We evaluated pre and post ET serum BDNF and proBDNF concentration (ELISA), heart rate (HR), mean blood pressure (MBP), forearm blood flow (FBF) and forearm vascular resistance (FVR). In the pre ET, BDNF, proBDNF, BDNF/proBDNF ratio, FBF and FVR were similar between all genotypes. After ET, functional capacity (VO2peak) increased and HR decreased similarly in both groups. Val66Val, but not Val66Met, increased BDNF (Interaction, p= 0.04) and BDNF/proBDNF ratio (Interaction, p < 0.001). Interestingly, FBF (Interaction, p=0.04) and the FVR (Interaction, p=0.01) responses during handgrip exercise improved in Val66Val compared with Val66Met, even with similar responses of HR and MBP. Further analyses showed association between BDNF/proBDNF ratio and FBF (R=0.64, p < 0.001) and FVR (R=-0.56, p < 0001). These results show that peripheral vascular reactivity and serum BDNF responses to ET are impaired by the BDNF Val66Met polymorphism and such responsiveness is associated to the serum BDNF concentrations in healthy subjects

Mental health has become a prominent issue in society. Yet, much remains unknown about the etiology of psychiatric disorders. The aim of the present thesis was to investigate the association between biological, psychological and social factors of risk and resilience and behavioral problems in a birth cohort of Swedish children. 1723 mothers and their children were followed from birth to the age of 12 as part of the South East Sweden Birth Cohort Study (the SESBiC study). Information was gathered through register data, standardized questionnaires and DNA samples. In study I, stability of maternal symptoms of depression and the impact on child behavior at age 12 were investigated. The prevalence of depressive symptoms was found to be 12.0 % postpartum. Symptoms of postpartum depression significantly increased the risk for subsequent depressive symptoms 12 years later in women. Children whose mothers reported concurrent symptoms of depression and anxiety had an increased risk for both internalizing and externalizing problems at age 12, but no long term effect on child behavior was seen for postpartum depressive symptoms. The greatest risk was seen for children whose mothers reported symptoms of depression on both occasions. In study II, the impact of gene-environment interaction of 5-HTTLPR and BDNF Val66Met and experience of life events together with symptoms of maternal depression and anxiety on child behavior at age 12 was studied. A main effect of 5-HTTLPR was noticed, but no geneenvironment effects were shown. Similarly to study I, concurrent symptoms of maternal depression and anxiety were an important predictor of child behavioral problems. A high degree of psychosocial stress around childbirth was found to have long lasting detrimental effects on child behavior, increasing the risk for internalizing problems at age 12. Study III investigated the impact of geneenvironment interactions of 5-HTTLPR and BDNF Val66Met and life events together with symptoms of maternal depression and birth characteristics on behavioral problems at age 3. Symptoms of postpartum depression were found to predict internalizing as well as externalizing problems in children three years later. Child experience of life events was a stable predictor of behavioral problems across the scales similar to sociodemographic factors such as parental immigration status and unemployment. No gene-environment interaction effects of 5-HTTLPR or BDNF Val66Met were shown. Study IV used the risk factors identified in studies I-III to investigate factors of resilience to behavioral problems at age 12. The l/l genotype of 5-HTTLPR was associated with a lower risk for behavioral problems at age 12, especially for children facing low adversity. Good social functioning was found to be a general resource factor, independent of the level of risk, while an easy temperament was associated with resilience for children with a high degree of adversity. However, effect sizes were small. In summary, the results from the present thesis emphasize the importance of maternal mental health and sociodemographic factors for child mental health at ages 3 and 12, which must be taken into account in clinical settings. Moreover, it adds to the null-findings of the gene-environment effect of 5-HTTLPR and BDNF Val66Met on behavioral problems in children, but indicates a main effect of 5-HTTLPR on internalizing symptoms at age 12.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-03-31T23:30:54Z No. of bitstreams: 1 FernandaCarvalhoCagni_DISSERT.pdf: 1786366 bytes, checksum: c9744d9e47a1b28a2acd8f572b07d5da (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-04-05T20:01:37Z (GMT) No. of bitstreams: 1 FernandaCarvalhoCagni_DISSERT.pdf: 1786366 bytes, checksum: c9744d9e47a1b28a2acd8f572b07d5da (MD5) / Made available in DSpace on 2016-04-05T20:01:37Z (GMT). No. of bitstreams: 1 FernandaCarvalhoCagni_DISSERT.pdf: 1786366 bytes, checksum: c9744d9e47a1b28a2acd8f572b07d5da (MD5) Previous issue date: 2015-05-12 / As doen?as neurodegenerativas s?o objeto frequente de estudo devido ao n?mero crescente de casos associados ao processo de envelhecimento populacional e pelo impacto que causam na qualidade de vida dos indiv?duos. A doen?a de Parkinson (DP) ? a segunda doen?a neurodegenerativa mais frequente. Apesar da sua etiologia ainda n?o ser completamente conhecida, sabe-se que a mesma ? causada por fatores ambientais e gen?ticos. Assim, a investiga??o dos fatores etiol?gicos e os mecanismos respons?veis pelas altera??es que levam a DP podem contribuir para o seu diagn?stico e preven??o. Uma poss?vel associa??o entre DP e o polimorfismo comum do Fator Neurotr?fico Derivado do C?rebro (BDNF) G196A (Val66Met) tem sido sugerido por diferentes estudos com resultados contrastantes. Por esse motivo, o objetivo deste estudo ? verificar se o polimorfismo BDNF Val66Met confere susceptibilidade a DP em uma amostra de pacientes brasileiros e se isso implica em quaisquer altera??es no n?vel de BDNF em sangue total e na manifesta??o de sintomas. A amostra foi constitu?da de pacientes acompanhados pelo servi?o de neurologia do Hospital Universit?rio Onofre Lopes (HUOL) e controles saud?veis (CTRL). Os aspectos motores da DP foram avaliados pela Escala de Hoehn e Yahr (HY), Unified Parkinson?s Disease Rating Scale (UPDRS) e Escala de Atividades Di?rias de Schwab e England (SE). Para a avalia??o dos aspectos n?o-motores foram utilizados os instrumentos: Bateria de Avalia??o Frontal (BAF), Mini Exame do Estado Mental (MEEM), Invent?rio de Depress?o de Beck (IDB) e o Invent?rio de Ansiedade de Beck (IAB). Amostras de sangue foram coletadas para a genotipagem do polimorfismo Val66Met e mensura??o da concentra??o de BDNF em sangue total. Como esperado, os pacientes com DP apresentaram pior desempenho na avalia??o motora, cognitiva e emocional. A distribui??o dos alelos entre os grupos n?o foi significativamente diferente, por?m o gen?tipo A/G foi associado significativamente como protetor para a DP. O gen?tipo G/G, por sua vez, foi associado significativamente com o desenvolvimento de depress?o e ansiedade em pacientes com DP. No entanto, as concentra??es de BDNF n?o foram diferentes entre os gen?tipos ou grupos. Este ? o primeiro estudo de associa??o gen?tica desse polimorfismo com a DP no Brasil e o primeiro que associou o heterozigoto A/G com prote??o contra a DP. / Neurodegenerative diseases are frequently studied due to the increasing number of cases associated with the populational ageing and to the impact on the conditions on the quality of life. Parkinson?s disease (DP) is the second most frequent neurodegenerative disease. Despite the fact that its etiology is not completely understood, it is known that DP is caused by environmental and genetic factors. Thus, the investigation of etiologic factors and mechanisms responsible for the changes that lead to DP may help early diagnostic and prevention. A possible association between DP and the common polymorphism of Brain Derived Neurotrophic Factor (BDNF) G196A (Val66Met) has been suggested by different studies with contrasting results. For this reason, the aim of this study is to investigate if the BDNF Val66Met polymorphism is related to susceptibility to DP in a cohort of Brazilian patients. Additionaly, we verify if the presence of the polymorphism implies in alterations in the BDNF whole blood concentrations, as well as variations in symptomatology. The sample comprised Brazilian patients accompanied by the neurology service of the Onofre Lopes University Hospital (HUOL) and healthy controls (CTRL). The motor aspects of DP were evaluated by Hoehn e Yahr Scale (HY), Unified Parkinson?s Disease Rating Scale (UPDRS) and Schwab & England Scale (SE). For the evaluation of non-motor symptoms were used the following instruments: Frontal Assessment Battery (BAF), Mini-Mental State Examination (MEEM), Beck Depression Inventory (IDB) and the Beck Anxiety Inventory (IAB). Blood samples were collected for BDNF Val66Met polymorphism genotyping and BDNF whole blood measurement. As expected, DP patients performed worse in motor, cognitive and emotional battery of questionnaires. Alleles distribution between DP and CTRL was not significantly different, but the A/G genotype was significantly associated with a protector factor for DP. In contrast, the G/G genotype was significantly associated with depression and anxiety development in DP patients. However, BDNF concentrations were not different between genotypes or groups. This is the first study of genetic association of this polymorphism with DP in Brazilian subjects and the first one that associate A/G genotype with protection against DP.